Key result
Pericardial effusion in infective endocarditis does not independently predict in-hospital mortality.
Why the study?
Pericardial effusion is widely believed to signify more advanced infective endocarditis and worse outcomes, but its prevalence and clinical significance in native and prosthetic valve infections required evaluation.
Does the presence of pericardial effusion predict worse clinical outcomes in patients with infective endocarditis?
Observational (n=338)
No
Does the presence of pericardial effusion predict worse clinical outcomes in patients with infective endocarditis?
Pericardial effusion in infective endocarditis is a marker of more severe infection and worse prognosis, though it is not an independent predictor of mortality.
Answers are grounded in this paper and cite their sources.
Pericardial effusion should not yet inform independent prognosis in infective endocarditis; leaves open its role as a severity marker in larger cohorts.
BACKGROUND: Pericardial effusion (PE) is widely believed to signify more advanced infective endocarditis (IE) and a generally worse outcome. PURPOSE: To determine the prevalence and clinical significance of PE in a series of patients with confirmed native and prosthetic valve infections. METHODS: Data were collected from 338 consecutive patients with definite or possible IE who visited a single referral center; these patients were examined for the presence of PE as detected by transthoracic echocardiography. Clinical characteristics, the incidence of complications, and outcomes were compared between patients with IE with and without PE. IE patients with PE were then divided into two subgroups: those with and those without cardiac prostheses. RESULTS: Eighty-eight patients out of the total 338 (26%) were found to have PE. Compared with patients who did not have PE, patients who did were significantly younger (32.9 ± 13.4 vs 29.0 ± 9.2, p = 0.003), had more left-sided vegetation (55.6% vs 77.3%, p < 0.001), more root abscesses (9.2% vs 25.0%, p < 0.001), needed surgery more frequently (68.0% vs 84.1%, p = 0.001), and had a higher mortality rate (22.0% vs 32.9%, p = 0.03). PE was not found to be a predictor of mortality. No significant difference was found between IE patients with PE with (n = 13) and without (n = 75) prostheses with regard to causative organisms, clinical characteristics, or clinical outcomes. CONCLUSION: Regardless of whether the IE was in native or prosthetic valves, compared with patients without PE, patients with PE had more severe infections and a worse prognosis, but PE was not an independent predictor of mortality.
No takes yet. Share an insight, caveat, or question.
Youssef et al. (2019) conducted an observational in Definite or possible infective endocarditis (native and prosthetic valve) (n=338). Pericardial effusion vs. No pericardial effusion was evaluated on In-hospital overall mortality (OR 1.97, 95% CI 1.6-3.4, p=0.08). Pericardial effusion in infective endocarditis was associated with higher crude mortality but did not independently predict mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: